|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Satsuma Pharmaceuticals, Inc. (STSA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
11 |
|
|
|
Total
Direct Shares :
|
3,836,146 |
|
|
Total
Indirect Shares :
|
42,291,984 |
| |
%
Held by Insiders:
|
12.17% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Shin Nippon Biomedical Laboratories, Ltd. |
10% Owner |
2023-06-08 |
2,560,780 |
2023-06-08 |
8,657,065 |
| Kollins John A |
President and CEO, Director |
2023-06-06 |
0 |
|
0 |
| Oneil Thomas P. |
Chief Financial Officer |
2023-06-06 |
0 |
2020-03-11 |
0 |
| Leonard Braden Michael |
10% Owner |
2022-11-21 |
150,000 |
2022-11-21 |
6,440,000 |
| Commodore Capital Lp |
10% Owner |
2021-10-15 |
0 |
2022-11-14 |
461,286 |
| Albrecht Detlef |
Chief Medical Officer |
2020-09-01 |
20,212 |
|
0 |
| Takanashi Ken |
Director, 10% Owner |
2019-09-17 |
0 |
2023-06-06 |
24,847,694 |
| Hadley Harbor Master Investors (cayman) Ii L.p. |
10% Owner |
2019-09-17 |
1,105,154 |
2019-09-17 |
0 |
| Kolchinsky Peter |
Former 10% Owner |
2019-09-17 |
0 |
2023-06-08 |
0 |
| Shah Rajeev M. |
Director, 10% Owner |
2019-09-17 |
0 |
2023-06-06 |
0 |
| Coulter James G |
10% Owner |
2019-09-17 |
0 |
2019-09-17 |
1,885,939 |
|
|
